CXCL17 induces activation of human mast cells via MRGPRX2

Jie Ding¹, Christina Hillig², Carl W White^{1

3}, Nithya A Fernandopulle¹, Holly Anderton⁴, Johannes S Kern^{5

6}, Michael P Menden^{1

2}, Graham A Mackay¹

Affiliations

¹ Department of Biochemistry and Pharmacology, The University of Melbourne, Parkville, Victoria, Australia.
² Helmholtz Zentrum München-German Research Centre for Environmental Health, Institute of Computational Biology, Neuherberg, Germany.
³ Australian Research Council, Centre for Personalised Therapeutics Technologies, Melbourne, Victoria, Australia.
⁴ Division of Inflammation, Walter and Elisa Hall Institute, Melbourne, Victoria, Australia.
⁵ Central Clinical School, Monash University, The Alfred Hospital, Melbourne, Victoria, Australia.
⁶ Department of Dermatology, Royal Melbourne Hospital, Melbourne, Victoria, Australia.

Jie Ding et al. Allergy. 2024 Jun.

. 2024 Jun;79(6):1609-1612.

doi: 10.1111/all.16036. Epub 2024 Jan 26.

Jie Ding¹, Christina Hillig², Carl W White^{1

3}, Nithya A Fernandopulle¹, Holly Anderton⁴, Johannes S Kern^{5

6}, Michael P Menden^{1

2}, Graham A Mackay¹

¹ Department of Biochemistry and Pharmacology, The University of Melbourne, Parkville, Victoria, Australia.
² Helmholtz Zentrum München-German Research Centre for Environmental Health, Institute of Computational Biology, Neuherberg, Germany.
³ Australian Research Council, Centre for Personalised Therapeutics Technologies, Melbourne, Victoria, Australia.
⁴ Division of Inflammation, Walter and Elisa Hall Institute, Melbourne, Victoria, Australia.
⁵ Central Clinical School, Monash University, The Alfred Hospital, Melbourne, Victoria, Australia.
⁶ Department of Dermatology, Royal Melbourne Hospital, Melbourne, Victoria, Australia.

No abstract available

References

1. Subramanian H, Gupta K, Ali H. Roles of mas‐related G protein‐coupled receptor X2 on mast cell‐mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseases. J Allergy Clin Immunol. 2016;138:700‐710.
1. Choreno‐Parra JA, Thirunavukkarasu S, Zuniga J, Khader SA. The protective and pathogenic roles of CXCL17 in human health and disease: potential in respiratory medicine. Cytokine Growth Factor Rev. 2020;53:53‐62.
1. Cao C, Kang HJ, Singh I, et al. Structure, function and pharmacology of human itch GPCRs. Nature. 2021;600:170‐175.
1. Nattkemper LA, Tey HL, Valdes‐Rodriguez R, et al. The genetics of chronic itch: gene expression in the skin of patients with atopic dermatitis and psoriasis with severe itch. J Invest Dermatol. 2018;138:1311‐1317.
1. Oka T, Sugaya M, Takahashi N, et al. CXCL17 attenuates imiquimod‐induced psoriasis‐like skin inflammation by recruiting myeloid‐derived suppressor cells and regulatory T cells. J Immunol. 2017;198:3897‐3908.